Ellen t'Hoen, of MSF, says that the US will have experienced a little of what developing countries suffer: What is very telling is that now the US and Canada are facing a shortage and a problem of providing the medicines that the government thinks are needed to protect health, the patent is a barrier to doing that and they are looking for ways of overcoming that.